Almasry Pharmacy

SALE

Effegad 75 Mg 14 Capsules

Short Description:
Effegad 75 mg 14 capsules is an extended-release venlafaxine antidepressant used to treat major depressive disorder and anxiety-related conditions in adults. It helps rebalance brain chemicals, improving mood, reducing anxiety, and supporting overall mental and emotional well-being under medical supervision.

EGP 73EGP 76

In Stock

delivery-iconDelivery to governorates within 3-4 working days
refund-iconEasy returns within 14 days
Specifications
SKUISG001221
BrandايفيجادLink Icon
Categories
Medication & Treatments
Color
black
Concentrations
75 Mg
Shop by ConcernsAnxiety DisorderLink Icon, DepressionLink Icon, Low MoodLink Icon, NervousnessLink Icon
Gender
Neutral
Shop By GoalsAnxiety ReliefLink Icon, Depression ManagementLink Icon, Mental PerformanceLink Icon, Mood StabilizationLink Icon
Imported Or LocalLocal
Ingredient
Venlafaxine
Product Form
Capsules
Specialty
Clinically Tested
Extended Release
Prescription only
Sub Categories
Anti Depressants
Unit Count
14 Capsules
Warning
Do Not Use With MAOIs
May increase blood pressure
Risk of serotonin syndrome
Risk of suicidal thoughts
Use under medical supervision
About the product

Effegad 75 Mg 14 Capsules

Description:

Effegad 75 mg 14 capsules is a prescription antidepressant medicine containing venlafaxine, a serotonin and norepinephrine reuptake inhibitor (SNRI). It is formulated as extended-release (e.r.) capsules to provide a controlled release of the active ingredient over the day, helping to manage major depressive disorder and anxiety-related conditions. Effegad 75 mg is designed for adult patients under medical supervision to improve mood, reduce anxiety, and support overall mental health balance.


Indications:

  • Treatment of major depressive disorder (MDD) in adults.
  • Management of generalized anxiety disorder (GAD), including persistent and excessive worry, restlessness, and irritability (as per venlafaxine indications).
  • Treatment of social anxiety disorder (social phobia), including fear and avoidance of social situations (as per venlafaxine indications).
  • Helps relieve associated symptoms such as low mood, loss of interest, fatigue, difficulty concentrating, and sleep disturbances related to depression and anxiety.
  • May be used as part of a long-term management plan for recurrent depressive episodes, as directed by a psychiatrist or healthcare professional.

Active Ingredients / Key Components:

  • Venlafaxine (as extended-release) – 75 mg per capsule.
  • Other inactive ingredients/excipients: Not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.). Full excipient list is not available; please refer to the package leaflet for complete details.

Dosage & Administration / How to Use:

  • Effegad 75 mg is for oral use only and should be taken exactly as prescribed by your doctor.
  • Typical adult starting dose for depression or anxiety disorders with venlafaxine e.r. is often 75 mg once daily; your doctor may adjust the dose based on response and tolerability. Exact dosing for this specific brand must be determined by the prescribing physician.
  • Take the capsule once daily at approximately the same time each day.
  • Swallow the capsule whole with water; do not crush, chew, or open the capsule, as this will affect the extended-release properties.
  • Can be taken with or without food; taking it with food may help reduce gastrointestinal discomfort.
  • Do not change the dose, skip doses, or stop taking Effegad 75 mg suddenly without consulting your doctor, as this may cause withdrawal symptoms.
  • If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed one.
  • Use only under medical supervision, especially in patients with liver, kidney, heart, or psychiatric conditions.

Clinical Benefits:

  • Helps restore the balance of serotonin and norepinephrine in the brain, improving mood and emotional stability.
  • Reduces core symptoms of depression such as sadness, hopelessness, lack of interest, and fatigue.
  • Alleviates symptoms of generalized anxiety disorder, including excessive worry, tension, and irritability.
  • Improves functioning in social anxiety disorder by reducing fear and avoidance of social situations.
  • Supports better sleep patterns and appetite in patients with depression or anxiety, as part of overall symptom improvement.
  • Extended-release formulation provides steady blood levels over 24 hours, which may enhance tolerability and convenience with once-daily dosing.

Warnings & Contraindications:

  • Contraindicated in patients with known hypersensitivity to venlafaxine or any of the capsule components.
  • Do not use concurrently with monoamine oxidase inhibitors (MAOIs) or within 14 days of stopping an MAOI; also allow sufficient washout period after stopping venlafaxine before starting an MAOI, as directed by your doctor.
  • May increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults, especially at the beginning of treatment or after dose changes. Close monitoring by a healthcare professional is essential.
  • Use with caution in patients with a history of bipolar disorder, mania, or hypomania; venlafaxine may precipitate manic episodes.
  • Use with caution in patients with cardiovascular disease, hypertension, or arrhythmias; venlafaxine can increase blood pressure and heart rate. Regular monitoring of blood pressure is recommended.
  • Use with caution in patients with liver or kidney impairment; dose adjustment may be required.
  • Risk of serotonin syndrome when used with other serotonergic drugs (e.g., other antidepressants, triptans, tramadol, St. John’s wort). Seek urgent medical help if symptoms such as agitation, confusion, sweating, tremor, or rapid heartbeat occur.
  • May cause drowsiness, dizziness, or blurred vision; avoid driving or operating machinery until you know how the medicine affects you.
  • Alcohol consumption should be limited or avoided, as it may increase certain side effects.
  • Consult your doctor before use if pregnant or planning pregnancy; venlafaxine should be used in pregnancy only if clearly needed and under specialist supervision.
  • Consult your doctor before use if breastfeeding; venlafaxine passes into breast milk, and a risk–benefit assessment is required.
  • Not recommended for children and adolescents unless specifically prescribed by a specialist.
  • Consult your doctor before use if you have glaucoma (especially narrow-angle), seizure disorders/epilepsy, bleeding disorders, or are taking anticoagulants or antiplatelet drugs.
  • Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
  • Keep out of reach of children.

Side Effects:
  • Common side effects may include nausea, dry mouth, headache, dizziness, insomnia or sleepiness, sweating, nervousness, decreased appetite, constipation, and sexual dysfunction (e.g., decreased libido, delayed ejaculation).
  • Other possible side effects include increased blood pressure, palpitations, tremor, blurred vision, and gastrointestinal discomfort.
  • Serious side effects (seek immediate medical attention) may include signs of serotonin syndrome (agitation, hallucinations, rapid heartbeat, fever, muscle stiffness), severe allergic reactions (rash, swelling of face or throat, difficulty breathing), seizures, severe mood changes, suicidal thoughts or behavior, or severe increase in blood pressure.
  • Discontinuation symptoms (e.g., dizziness, sensory disturbances, sleep disturbances, irritability, headache, nausea) may occur if the medicine is stopped abruptly; always taper under medical supervision.
  • This is not a complete list of side effects. For full safety information, consult your doctor or pharmacist and read the patient information leaflet.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.


Specifications:
  • Product type: Prescription antidepressant medicine (SNRI).
  • Active ingredient: venlafaxine 75 mg per extended-release capsule.
  • Form: Capsule (extended-release).
  • Pack size: 14 capsules per pack.
  • Intended use: Adult patients for the treatment of depression and anxiety disorders under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.

More fromايفيجاد

See More

Product Reviews

Overall Rating
0

Based on 0 reviews

Warning iconYou can add a rating once you purchase the product through the My Orders page

Customer Reviews
No reviews yet
TelegramWhatsApp